INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 13, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 718 | $579.35 | 40,721 |
| Aug 13, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,755 | $579.35 | 36,966 |
| Aug 13, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 250 | $579.35 | 41,452 |
| Aug 13, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,146 | $579.35 | 39,306 |
| Nov 02, 2015 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Open market or private sale of non-derivative or derivative security | 1,500 | $579.53 | 543,748 |
| Sep 06, 2022 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 7 | $579.67 | 19,657 |
| Sep 06, 2022 |
Director
Trans History: 48
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 550 | $579.85 | 5,470 |
| Jul 06, 2021 |
EVP General Counsel and Secret
Trans History: 181
|
EVP General Counsel and Secret | Form 4 | Open market or private sale of non-derivative or derivative security | 3,398 | $580.00 | 13,182 |
| May 28, 2020 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 500 | $580.00 | 2,900 |
| May 13, 2020 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $580.00 | 115,415 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.